Skip to main content

Advertisement

Table 1 Characteristics of the successfully cardioverted atrial fibrillation patients

From: Effect of sinus rhythm restoration on markers of thrombin generation in atrial fibrillation

Variable n = 134
Medical history
 Age (years) 64 ± 11
 Sex (women/men) 33/101
 Body mass index (kg/m2) 26 ± 4
 Hypertension 38 (28%)
 Coronary heart disease 12 (9%)
 Diabetes 10 (7%)
 Chronic obstructive pulmonary disease 7 (5%)
 Current cigarette smoking 21 (16%)
 CHA2DS2-VASc score 1.5 ± 1.3
Medication at randomisation
 Angiotensin receptor blocker/study drug 66 (49%)
 Digitalis 16 (12%)
 Beta-blockers 48 (36%)
 Calcium channel blockers 63 (47%)
 Diuretics 11 (8%)
 Statins 18 (13%)
Blood pressure and heart rate
 Systolic blood pressure (mmHg) 134 ± 18
 Diastolic blood pressure (mmHg) 82 ± 8
 Ventricular heart rate (beats per minute) 85 ± 17
Echocardiographic assessments
 Left atrial systolic diameter (mm) 46 ± 6
 Left atrial systolic area (cm2) 27 ± 5
 Fraction of shortening (%) 30 ± 7
  1. Baseline clinical characteristics of the 134 successfully cardioverted patients in the Candesartan in the Prevention of Relapsing Atrial Fibrillation (CAPRAF) study. Values presented as mean ± standard deviation or number (%). Abbreviations: CHA 2 DS 2 -VASc score A measure of stroke risk in patients with atrial fibrillation, with scores ranging from 0 to 9 and higher scores indicating greater risk, n Number of patients